02.03.2022 Views

03-03-2022

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

THursDAy, mArCH 3, 2022

5

EmIlIE FIlOu

The boarding of Uganda Airlines flight

446 from Entebbe to Dubai was

momentarily disrupted at the end of last

year when two of the passengers started

hawking bush crickets in the aisles.

Their fellow travellers couldn't believe

their luck: nsenene are a prized delicacy

in Uganda, but despite November

usually being peak season for the

insects, there had been hardly any

around.

The video from the plane went viral;

there were grumblings about security

breaches, but Uganda Airlines seemed

sympathetic and spotted an

opportunity to turn the crisis into an

opportunity. "We understand that

[nsenene] was not in plenty this season,

hence the excitement. We are

considering adding nsenene to our

menu for regional and international

flights on request," it said in a

statement.

Nsenene are just one of 2,100 known

edible insect species, a quarter of which

are consumed in Africa. Most are highly

prized - often costing more than beef or

chicken by weight - and most are

harvested from the wild.

Catching them is often difficult, they

are seasonal and can be unavailable

when most needed, said Dorte Verner,

lead agriculture economist at the World

Bank's food and agriculture global

practice. They can also be overharvested

or contaminated with

pesticides.

However, with rising food insecurity,

safeguarding this nutritious source of

protein has become critical. "In 2021,

Are farmed insects the next big thing in food industry?

21% of people in countries affected by

fragility, conflict and violence did not

have access to nutritious food," said

Verner. "Also, food production per

capita has been falling since 2014."

Farming the insects is one solution. A

recent report, published by Verner and

World Bank colleagues, on the potential

of hydroponics and insect farming in

Africa, found 849 farms in 10 of the 13

countries they surveyed. While still in

its infancy - most farms were set up in

the last decade - the industry has clear

potential: not only would insects be

available all year, it would create jobs,

help manage food waste, which is used

as feed, and insect manure, or frass,

could create fertilisers.

The World Bank has estimated that

within a year, black soldier fly (BSF)

farming could generate crude protein

worth up to $2.6bn (£1.9bn) and

biofertilisers worth up to $19.4bn. The

process would recycle 200m tonnes of

crop waste.

Although the bulk of existing farms

produce insects for human

consumption, there has been growing

interest in insects as animal feed.

Demand has trebled in the last decade

in Kenya alone, and feed manufacturers

have been increasingly looking for

alternatives to soya and fishmeal, which

are plagued by volatile prices, variable

quality and poor environmental

records.

Nsenene, or bush crickets, are just one of 2,100 known edible insects species, a quarter of which are consumed

in Africa.

Photograph: Eugénie Baccot

Research suggests that animals fed

insect protein, notably BSF, achieved

faster growth rates and better-quality

meat than with soya or fishmeal.

Production costs are relatively stable,

and will go down as operations are

scaled up, said Talash Huijbers, founder

of InsectiPro, one of the largest BSF

farms in Kenya. "With the pandemic,

people are starting to appreciate the

value of local protein production," she

said. Shobhita Soor, head of Legendary

Foods, a palm weevil farm in Ghana,

has seen similar trends. Many of her

customers want to eat "made in Ghana"

products.

Soor's ambition is to "deliver the

nutrition of meat at the price point and

sustainability of plant", a mission that

has led to a relentless search for

efficiency gains. "Last year, we managed

to reduce our costs of production by

40%. If we want to be as ubiquitous as

chicken, it's incumbent on us to do the

R&D to continue to optimise our

production."

She is looking to raise $5m this year to

build her first large-scale plant, while

InsectiPro is planning an $11m

expansion: it has already opened two

more BSF facilities in Kenya and wants

to expand in Uganda and Rwanda.

Only 16 species are farmed in Africa,

but the International Centre of Insect

Physiology and Ecology in Kenya has

been looking at how to raise various

insect species since 2014 and has

trained thousands of would-be

"entopreneurs".

Publications such as the World Bank

report are vital to put insect protein on

the radar of governments - insects do

not appear in any national food

strategy. Other large development

finance institutions, such as the

International Finance Corporation and

the US Agency for International

Development, are also looking into

insect farming. Meanwhile, the World

Bank is planning pilot investments in

South Sudan, Malawi, Kenya and

Zimbabwe.

"From the number of meeting

requests I have received since the

publication of the report, I can tell you

that [people] are really interested," said

Verner.

Affordable analysis

of genomes key to

tackling diseases

ONyANGO NyAmOl

A project equipping

researchers with cheap and

accessible methods for

studying genetic materials of

large collections of bacteria

that cause diseases could be

critical in tackling future

global health challenges,

scientists say.

The 10,000 Salmonella

Genomes Project (10KSG)

could make bacterial genomic

data more accessible in lowand

middle-income

economies, especially in Sub-

Saharan Africa where 80 per

cent of the 77,000 global

annual deaths from nontyphoidal

Salmonella

bloodstream infections occur.

The collaboration of

scientists from 16 countries,

led by the Earlham Institute

and the University of

Liverpool in England, aims to

understand the genetic

makeup of bacterial strains

responsible for Salmonella

bloodstream infections in

Africa and Latin America. This

can increase understanding of

drug resistance and virulence

of the bacteria and help in the

development of vaccines.

"Infectious diseases cause a

huge health and economic

burden on low- and middleincome

countries," says Neil

Hall, director of the Earlham

Institute, a life science

research centre.

"Usually, the most effective

interventions involve public

health measures. However,

public health policy needs to

be well informed by good data

from genomic epidemiological

studies."

In less than a year, scientists

have analysed 10,000

Salmonella genomes from

Africa and Latin America for

as little as US$10 per genome

A project is aiding resource-limited scientists to analyse deadly microbes' genetic

materials .

Photo: Pixaby

or genetic material.

According to researchers,

large-scale bacterial genome

analyses have been possible in

only a few sequencing centres

globally until now and the cost

had been as much as US$100

per genome.

The 10KSG project, Hall

explains, has significantly

reduced the cost and

increased the large-scale study

of genetic materials present in

microbes, enabling many

more scientists to access the

technology worldwide.

Jay Hinton, a professor of

microbial pathogenesis from

the University of Liverpool,

says that for any vaccines to be

effective, there is a need to

know more about the bacteria

causing the disease.

"Our project has provided

the best understanding of the

Salmonella variants

responsible for bloodstream

infections in African countries

including Democratic

Republic of Congo, Gambia,

Mali, Malawi, Kenya, Senegal

and Uganda in recent years -

information that will be

invaluable for evaluating the

impact of the [Salmonella]

vaccine rollout," Hinton

explained.

Damaris Matoke-Muhia, a

molecular biologist at the

Kenya Medical Research

Institute (KEMRI), says that

people trained in sequencing

can train others, in order to

build a qualified workforce.

"Once the facilities are

equipped with sequencing

tools, it will help with

continuous sequencing of

genomes of interest and this

will stop the shipment of

samples that is usually done

due to lack of capacity,

including sequencing SARS-

CoV-2 variants," Matoke-

Muhia tells.

Sultan Mahmud Khan Rony: a

torch bearer for country’s youth

AzHAr AlI, BOGurA

COrrEsPONDENT

The Bogura District Awami

League Publicity and

Publication Secretary Sultan

Mahmud Khan Rony has been

spotlighted as the beacon for

the country's youth. He has

been polite and thoughtful

since his childhood.He is

dedicated to literature, culture

and sports. As per him, in order

to build a strong nation,

intelligence, tolerance and

innovative skills must be

awakened in the youth. Their

leadership will take the country

to the forefront of the world. In

this case, the most important

thing is to curate sports-loving

and culture-oriented minds

among youth. As a result, the

youth get the openness of life,

the formidable attitude of life

struggle, and gain success. By

them this society will become

free of drug abuse, terror, and

militancy.

Father of the Nation

Bangabandhu Sheikh Mujibur

Rahman was a sports minded

and culture oriented person

from his childhood. He became

the leader of the nation at the

time when he first led a sports

team at his early age. In order

for this nation to be known as

the richest nation in the world,

the young people have to be

rony poses for a portrait.

managed properly. The youth

are the shining stars of the

country, nation and society, the

future leaders of the nation. In

order to make them drug free,

they have to develop sports and

culture. The country has

enough youth dependent

energy. It is our responsibility

Photo: TBT

to harness this power. It is with

this thought that Sultan

Mahmud Khan Rony, the

aspiring leader of the youth

society of Bogura, made such

an effort to build the youth

society as enlightened people.

He has continued to support

the neglected, miserable,

disenfranchised and coldblooded

people of the society.

He has distributed food

items, health items and cash

during the Covid-19 pandemic.

In particular, he provided

financial assistance to poor

meritorious students and

sports. In the past, this young

leader was former VP of

Bogura Government Shah

Sultan College Student

Parliament, GS, District

Chhatra League Social Welfare

Secretary, Joint Convener,

General Secretary, Municipal

Awami League Joint Convener

and now District Awami

League Publicity and

Publication Secretary. Besides,

he is currently directly and

indirectly involved with various

social, cultural and educational

institutions including panel

chairman of Bogura district

council, additional general

secretary of district sports

body, president of district

football association, life

member of Bogura Diabetes

Association

He has been able to place

himself in the heart of the mass

by his good behavior.

Especially the entrepreneurial,

sports-loving, literary-minded,

culture-minded people who are

creative thinkers, nurture him

as a source of encouragement.

EsTHEr NAkkAzI

Six African countries are to receive

technology that will enable them to

manufacture COVID-19 vaccines, in an

effort to reduce reliance on producers

outside the continent, the World Health

Organization (WHO) has announced.

Egypt, Kenya, Nigeria, Senegal, South

Africa and Tunisia will get access to the

messenger RNA (mRNA) vaccine

technology along with knowledge

needed to manufacture the vaccines

and support in training scientists, the

WHO said.

The rollout is part of a global initiative

aimed at helping low- and middleincome

countries to access the

technology for producing mRNA

vaccines at scale and to international

standards in order to stem the COVID-

19 pandemic.

MRNA vaccines, used by Pfizer-

BioNTech and Moderna for their shots,

work by instructing cells to produce a

protein which triggers an immune

response to fight viruses when they

enter the body. These two companies

have so far delivered the majority of

their doses to rich countries, leaving

lower-income countries out in the cold.

"No other event like the COVID-19

pandemic has shown that reliance on a

few companies to supply global public

Africa’s COVID-19 fight bolstered with tech transfer

goods is limiting, and dangerous," said

WHO director-general Tedros

Adhanom Ghebreyesu, at a ceremony

on Friday (18 February) hosted by the

European Council, France, South Africa

and the WHO during the European

Union-African Union summit in

Brussels.

The announcement was greeted with

excitement in Africa where only about

12 per cent of the population are fully

vaccinated against COVID-19,

according to data from the Africa

Centres for Disease Control and

Prevention (Africa CDC).

"I'm really pleased to see this

progress," said Africa CDC director

John Nkengasong." The way we fight

the next pandemic will be very

different because the continent would

have been producing diagnostics and

vaccines."

The development follows the creation

of an mRNA vaccine technology

transfer hub run by a WHO consortium

in South Africa, which will share

technical know-how with vaccine

manufacturers in the six countries.

The WHO and partners will train and

help build up the necessary workforce

across the value chain, said Tedros, with

a training hub to be announced in the

coming weeks.

South African president Cyril

Ramaphosa said that enabling Africa to

make its own vaccines meant "mutual

respect and recognition of what we can

all bring to the party, investment in our

economies, infrastructure investment

and, in many ways, giving back to the

continent".

He added: "Organisations such as

COVAX [the initiative for equal access

to COVID-19 vaccines] and Gavi [the

Vaccine Alliance] need to commit to

buying vaccines from our local

manufacturers. They need to buy them

from the locally produced hubs once

they get going."

Ramaphosa also called upon

European countries to approve an

intellectual property waiver on COVID

technology, which has been before the

World Trade Organization for over a

year.

"Governments that are really serious

about ensuring that the world has

access to vaccines should ensure that we

approve the TRIPS [Trade-Related

Aspects of Intellectual Property Rights]

waiver as we've put it forward," he

added.

Ultimately the mRNA tech transfer

hub will promote access to vaccines for

everyone, strengthen health security

and promote self-reliance for the future,

according to the WHO. It says the

technology can also be used for insulin

to treat diabetes, cancer medicines and,

potentially, vaccines for diseases such

as malaria, tuberculosis and HIV.

"Diversifying mRNA vaccine

manufacturing capacity to low- and

middle-income countries should be a

global health priority," said Doctors

Without Borders (MSF), in response to

the WHO announcement.

"More regions producing mRNA

vaccines as essential preparedness

against infectious diseases could bolster

the response not only to COVID-19 and

future infectious diseases, but also

potentially to existing ones such as

malaria, tuberculosis and HIV."

German biotechnology company

BioNTech announced on Wednesday

(16 February) that it will create

accessible technology for mRNA

manufacturing in Rwanda and Senegal

in 2022 - with a fill-and-finish

collaboration in Ghana. Fill-and-finish

is the process of filling vials with vaccine

and finishing the process of packaging

the medicine for distribution.

Earlier this month Afrigen, which is

part of the WHO's South Africa

consortium, announced it had

developed its own version of an mRNA

shot, based on publicly available data on

the composition of the Moderna

vaccine, to be tested in the coming

months.

Patrick Tippoo, executive director of

the Africa Vaccine Manufacturing

Initiative (AVMI), told SciDev.Net that

while access to technology in terms of

written recipes and permission to use

them was important, Africa needed to

be confident of securing and sustaining

a market for its products.

The WHO has announced that six African countries are to receive technology

to enable them to manufacture COVID-19 vaccines. Photo: Hakan German

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!